• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

Introduction to 6-Amino-2-fluoropyridine-3-carbaldehyde (CAS No: 1289132-52-0)

6-Amino-2-fluoropyridine-3-carbaldehyde is a fluorinated pyridine derivative that has garnered significant attention in the field of pharmaceutical and chemical research due to its versatile structural framework and potential biological activities. This compound, identified by the CAS number 1289132-52-0, features a reactive aldehyde group at the 3-position and an amino group at the 6-position, coupled with a fluorine substituent at the 2-position. These functional groups make it a valuable intermediate in the synthesis of various pharmacologically relevant molecules.

The significance of 6-Amino-2-fluoropyridine-3-carbaldehyde lies in its ability to serve as a building block for the development of novel therapeutic agents. Pyridine derivatives are well-documented for their role in medicinal chemistry, particularly in the design of drugs targeting neurological disorders, infectious diseases, and cancer. The introduction of fluorine into the pyridine ring enhances metabolic stability and binding affinity, which are critical factors in drug design. The presence of both an amino and an aldehyde group provides multiple sites for chemical modification, enabling the synthesis of complex molecular architectures.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors for kinases and other enzyme targets involved in cancer progression. 6-Amino-2-fluoropyridine-3-carbaldehyde has been explored as a key intermediate in the synthesis of kinase inhibitors due to its ability to form hydrogen bonds and participate in hydrophobic interactions with target proteins. For instance, studies have demonstrated its utility in constructing analogs of known kinase inhibitors, such as Janus kinase (JAK) inhibitors, which are crucial in treating autoimmune diseases like rheumatoid arthritis.

Moreover, the fluorinated pyridine core has been implicated in enhancing drug delivery systems. The fluorine atom can influence pharmacokinetic properties by affecting lipophilicity and cell membrane permeability. This has led to investigations into using 6-Amino-2-fluoropyridine-3-carbaldehyde as a precursor for developing prodrugs that exhibit improved bioavailability and targeted release profiles. Such advancements are particularly relevant in oncology, where efficient drug delivery is essential for maximizing therapeutic efficacy while minimizing side effects.

The aldehyde functionality at the 3-position of 6-Amino-2-fluoropyridine-3-carbaldehyde (CAS No: 1289132-52-0) further expands its synthetic utility. Aldehydes are versatile reagents that can undergo condensation reactions with various nucleophiles, including amines, hydrazines, and phenols, to form imines, hydrazones, and Schiff bases, respectively. These derivatives have been widely studied for their antimicrobial, anti-inflammatory, and anticancer properties. By leveraging these reactions, researchers have synthesized a library of compounds derived from 6-Amino-2-fluoropyridine-3-carbaldehyde, each with distinct pharmacological profiles.

Recent studies have also highlighted the role of fluorinated pyridines in modulating immune responses. The fluorine atom can act as a bioisostere for hydrogen atoms, altering electronic properties and influencing receptor binding affinity. This has prompted investigations into using 6-Amino-2-fluoropyridine-3-carbaldehyde as a scaffold for designing immunomodulatory agents. For example, researchers have explored its potential in developing small molecules that interact with immune checkpoint proteins, such as PD-L1 and CTLA-4, which are pivotal in regulating immune tolerance and antitumor immunity.

The chemical synthesis of 6-Amino-2-fluoropyridine-3-carbaldehyde involves multi-step processes that require precise control over reaction conditions to ensure high yield and purity. Common synthetic routes include fluorination of pyridine precursors followed by functional group interconversion to introduce the amino and aldehyde groups. Advances in catalytic methods have enabled more efficient and sustainable synthesis pathways, reducing waste generation and energy consumption. These improvements align with global efforts to promote green chemistry principles in pharmaceutical manufacturing.

In conclusion,6-Amino-2-fluoropyridine-3-carbaldehyde (CAS No: 1289132-52-0) is a multifaceted compound with significant potential in drug discovery and development. Its unique structural features make it an invaluable intermediate for synthesizing molecules with diverse biological activities. As research continues to uncover new therapeutic applications for fluorinated pyridines,6-Amino-2-fluoropyridine-3-carbaldehyde is poised to play an increasingly important role in addressing unmet medical needs across various disease areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)